Immunoadjuvants for cancer immunotherapy

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorCarmona-Ribeiro, Ana Maria-
Data de aceite: dc.date.accessioned2025-08-21T17:26:50Z-
Data de disponibilização: dc.date.available2025-08-21T17:26:50Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2023-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1016/B978-0-443-18770-4.00004-4-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/301699-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/301699-
Descrição: dc.descriptionIn cancer immunotherapy host immunity is recruited to kill cancer cells; approved clinical use of checkpoint inhibitors, for most patients, only partially removed the inhibition of T-cell functions against tumors, systemic T-cell responses have not been sufficient, low immunogenicity and the immunosuppressive environment of tumors have also been challenging for therapeutic efficiency in the clinic. Nanotechnology’s exponential growth has brought further developments for cancer immunotherapy. In this review, we mainly address how nanoengineered vaccines, combinatory therapies, oncolytic viruses and viral vectors, and nanostructures of diverse composition can induce robust T-cell responses against tumors and how nanomedicine can remodel the tumor immunosuppressive microenvironment to boost antitumor immune responses.-
Descrição: dc.descriptionBiocolloids Laboratory Biochemistry Department Chemistry Institute São Paulo State University-
Descrição: dc.descriptionBiocolloids Laboratory Biochemistry Department Chemistry Institute São Paulo State University-
Formato: dc.format1-36-
Idioma: dc.languageen-
Relação: dc.relationNanomedicine in Cancer Immunotherapy-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectAdjuvants for immunotherapy-
Palavras-chave: dc.subjectcellular immunotherapy-
Palavras-chave: dc.subjectchimeric antigen receptor-T cell-
Palavras-chave: dc.subjectcytokines-
Palavras-chave: dc.subjectimmune checkpoint blockade-
Palavras-chave: dc.subjectnanomaterials-
Palavras-chave: dc.subjectnanovaccines-
Palavras-chave: dc.subjecttoll-like receptor agonists-
Palavras-chave: dc.subjecttumor lysates as adjuvants-
Título: dc.titleImmunoadjuvants for cancer immunotherapy-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.